GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
ChromaDex Corp (CDXC) [hlAlert]

Rating:
Buy CDXC
3 Months Gains
down 11.15 %

ChromaDex Corp: OTC:CDXC quotes & news (CDXC) rated Buy with price target $2.25 by Dawson James

Posted on: Tuesday,  Oct 5, 2010  11:25 AM ET by Dawson James

ChromaDex Corp: OTC:CDXC quotes &
news (CDXC) rated Buy with price target $2.25 by Dawson James.

ChromaDex Corporation (ChromaDex), formerly Cody Resources, Inc, is a supplier of phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. On May 21, 2008, Cody Resources, Inc. (Cody) entered into an Agreement and Plan of Merger (the Merger Agreement), by and among Cody, CDI Acquisition, Inc. and wholly owned subsidiary of Cody (Acquisition Sub), and ChromaDex, Inc. (the Merger). Subsequent to the signing of the Merger Agreement Cody changed its name to ChromaDex Corporation. The business of ChromaDex is conducted by its principal subsidiaries, ChromaDex, Inc. and Chromadex Analytics, Inc. Chromadex Analytics, Inc.

Dawson James Securities is a full service investment firm with deep expertise in healthcare, biotechnology and technology with a staff of over 50 investment professionals ensures our clients stay ahead of the constant changes in the healthcare capital markets. From our widely-respected institutional research, investment banking and high net worth services to our personalized attention for individual accounts, we provide quality service for our clients. We take pride in the quality and depth of our professionals and encourage you to contact us so we can begin serving your financial needs today.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/5/2010 11:25 AM Buy
None
1.30 2.25
as of 12/31/2010
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy